0508usdM

FX Update: EURJPY overextended if EU outlook sours again.

Forex 4 minutes to read
Picture of John Hardy
John J. Hardy

Global Head of Macro Strategy

Summary:  The rise in yields after a weak T-bond auction yesterday has largely been erased in pre-New York trading today as risk sentiment soured in Europe, possibly on COVID-19 news flow combined with weak employment data. The euro is under modest pressure and EURJPY looks a bit over-extended to the upside if we are set for a bout of concern on the EU growth outlook.


Yesterday saw bond yields edging higher still after a weak US 30-year T-bond auction that saw the lowest bid-to-cover ratio (2.14) since 2019, but the move lower from the closing price on Wednesday was already almost entirely erased by late morning in Europe this morning, so volatility around the move has been fairly muted – USDJPY had a go at 107.00 but has eased back lower and  most other FX pairs are boxed into narrow trading ranges. One exception to that in JPY crosses is EURJPY, where we wonder if the pair is overextended to the upside, given fresh COVID-19 breakout fears across much of Europe and the very weak Q2 employment numbers, which registered a -2.9% drop year-on-year, the worst ever, despite EU countries’ furlough and other programmes aimed at keeping workers nominally employed.

The Aussie could hardly muster a reaction overnight to RBA Governor Lowe indicating to a parliamentary committee that the latest outbreak is hampering the recovery and that he would like for the Aussie to be lower. Clearly, the RBA will have to up its game if it wans to keep a lid on the Aussie when iron ore prices are within 10% of their highest price stretching back to 2013 (when the CNY was some 10% stronger, by the way). The market is rightfully taking the RBNZ at its word on currency as it has a history of intervention and touted its “active preparation” for a negative rate policy. This has helped keep AUDNZD well clear of the recent 1.0865 break that could be opening up for a major move higher to 1.12-1.13. New Zealand’s renewed struggle with a COVID-19 outbreak after no new cases for months is another factor weighing on the NZD.

As for US yields, we continue to watch closely as a critical market input, but recognize that a challenge of perhaps 100 basis points in the US 10-year yield benchmark (currently 70 bps), for example, may be needed to set the market on edge.

US weekly claims data was rather positive yesterday, with the initial claims registering a chunky >300k drop to 865k and the continuing claims posting a 600k drop to below 15.5M. Today we have a look at US Retail Sales data, which gets increasingly interesting from here with the attenuation of the generosity of the CARES act payments after the end of July. The stimulus thrown at the economy during the lockdown was so generous that Retail Sales almost managed to bounce back to a new all-time high in June despite a cratering economy in Q2.

EM focus
Action in EM is a bit more engaging than what we are seeing in G-10 currencies, as USDTRY edges above the highest close for the cycle and the lira has now devalued some 5% beyond the perceived 7.00 level in USDTRY. The Turkish central bank will meet to set rates next Thursday and the government there has already pulled back from some of its credit stimulus excesses in recognition of the curency’s plight. Much more – and likely a series of rate hikes so despised by the country’s leadership – is needed to stabilize the currency. Elsewhere in EM, MXN is actually stronger against the USD after the expected 50-bps rate cut to 4.50% yesterday. The central bank’s statement positioned any further cuts on developments in inflation, which has rebounded back above 3.0%, so we’re likely close to or have just seen the last cut for the cycle. For Russia and the ruble (RUB), meanwhile, we are eyeing the situation in Belarus, where there are widespread protests against the election results – also with the participation of factory workers.  Russian involvement if the Belarusian government comes under pressure could bring with it the risk of sanctions and a therewith a threat to the ruble.

Chart: USDCAD
CAD and NOK have moved rather aggressively higher over the last week, clearly in part on crude oil prices trading near recent highs and perhaps as well on hopes that an imminent vaccine will encourage a demand rebound for energy that could meet some degree of supply shock in the months ahead after some production and especially investment has been shut down due to the collapse in prices over the COVID-19 crisis. USDCAD took out the major 1.3350-00 area on the way down, a bearish development. The bears are in good shape with a bit of fresh momentum over the prior two sessions helping avoid a “triple divergence”, but the outlook lower could hinge on new highs in oil prices and equities that haven’t been forthcoming today – quite the contrary. Stay tuned – the bulls still need a strong comeback above 1.3300-50 and then some to signal any trend reversal potential, while bears will continue to eye the next major hurdle at 1.3000 if risk sentiment and oil prices avoid any sizable consolidation.

14_08_2020_JJH_Update_01
Source: Saxo Group

Outrageous Predictions 2026

01 /

  • Executive Summary: Outrageous Predictions 2026

    Outrageous Predictions

    Executive Summary: Outrageous Predictions 2026

    Saxo Group

    Read Saxo's Outrageous Predictions for 2026, our latest batch of low probability, but high impact ev...
  • A Fortune 500 company names an AI model as CEO

    Outrageous Predictions

    A Fortune 500 company names an AI model as CEO

    Charu Chanana

    Chief Investment Strategist

    Can AI be trusted to take over in the boardroom? With the right algorithms and balanced human oversi...
  • Dollar dominance challenged by Beijing’s golden yuan

    Outrageous Predictions

    Dollar dominance challenged by Beijing’s golden yuan

    Charu Chanana

    Chief Investment Strategist

    Beijing does an end-run around the US dollar, setting up a framework for settling trade in a neutral...
  • Obesity drugs for everyone – even for pets

    Outrageous Predictions

    Obesity drugs for everyone – even for pets

    Jacob Falkencrone

    Global Head of Investment Strategy

    The availability of GLP-1 drugs in pill form makes them ubiquitous, shrinking waistlines, even for p...
  • Dumb AI triggers trillion-dollar clean-up

    Outrageous Predictions

    Dumb AI triggers trillion-dollar clean-up

    Jacob Falkencrone

    Global Head of Investment Strategy

    Agentic AI systems are deployed across all sectors, and after a solid start, mistakes trigger a tril...
  • Quantum leap Q-Day arrives early, crashing crypto and destabilizing world finance

    Outrageous Predictions

    Quantum leap Q-Day arrives early, crashing crypto and destabilizing world finance

    Neil Wilson

    Investor Content Strategist

    A quantum computer cracks today’s digital security, bringing enough chaos with it that Bitcoin crash...
  • SpaceX announces an IPO, supercharging extraterrestrial markets

    Outrageous Predictions

    SpaceX announces an IPO, supercharging extraterrestrial markets

    John J. Hardy

    Global Head of Macro Strategy

    Financial markets go into orbit, to the moon and beyond as SpaceX expands rocket launches by orders-...
  • Britain’s Great EU Backdoor Return

    Outrageous Predictions

    Britain’s Great EU Backdoor Return

    Neil Wilson

    Investor Content Strategist

    Faced with rolling fiscal, economic, trade and political crises the UK government sneaks back into t...
  • Taylor Swift-Kelce wedding spikes global growth

    Outrageous Predictions

    Taylor Swift-Kelce wedding spikes global growth

    John J. Hardy

    Global Head of Macro Strategy

    Next year’s most anticipated wedding inspires Gen Z to drop the doomscrolling and dial up the real w...
  • Despite concerns, U.S. 2026 mid-term elections proceed smoothly

    Outrageous Predictions

    Despite concerns, U.S. 2026 mid-term elections proceed smoothly

    John J. Hardy

    Global Head of Macro Strategy

    In spite of outstanding threats to the American democratic process, the US midterms come and go cord...

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details. Past Performance is not indicative of future results.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992